Healthcare / Medical Care FacilitiesTokyo
$207.00
-3.00 (-1.43%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $394.0M · quality 25.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.3B
P/E
4.4x
↓EV/EBITDA
9.2x
↓ROE
29.9%
↑Gross Margin
13.1%
↓Debt/Equity
9.74
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.2%
FCF CAGR
—
FCF margin
1.5%
FCF / Net income
0.62x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.83B · net income $444.0M · FCF $275.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.83B | $17.83B | $17.30B | $16.44B | $15.75B |
| Net Income | $444.0M | $444.0M | $203.0M | $-276.0M | $-319.0M |
| EBITDA | $1.66B | $1.66B | $1.45B | $831.0M | $726.0M |
| EPS | 39.65 | 39.65 | 18.12 | -24.66 | -28.36 |
| Gross Margin | 13.1% | 13.1% | 12.8% | 9.7% | 9.8% |
| Operating Margin | 5.0% | 5.0% | 4.4% | 0.8% | 1.2% |
| Net Margin | 2.5% | 2.5% | 1.2% | -1.7% | -2.0% |
| Balance Sheet | |||||
| Debt/Equity | 9.74 | 9.74 | 14.02 | 17.59 | 13.69 |
| Current Ratio | 0.74 | 0.74 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $275.0M | $275.0M | $995.0M | $394.0M | $-984.0M |
| Returns | |||||
| ROE | 29.9% | 29.9% | 18.7% | -31.0% | -27.6% |
| Valuation | |||||
| P/E | 4.44 | 4.44 | 13.36 | — | — |
| EV/EBITDA | 9.25 | 9.25 | 11.22 | 19.87 | 23.27 |
| P/B | 1.56 | 1.56 | 2.50 | 2.15 | 1.60 |
| Growth & Yield | |||||
| Revenue Growth | 3.0% | 3.0% | 5.2% | 4.4% | — |
| EPS Growth | 118.8% | 118.8% | 173.5% | 13.0% | — |
| Dividend Yield | 3.8% | 3.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-22.6%
EPS terminal req.
$18.37
Spread vs growth
141.4%
5Y implied EPS CAGR
-10.9%
EPS terminal req.
$22.23
Spread vs growth
129.8%
10Y implied EPS CAGR
-1.0%
EPS terminal req.
$35.79
Spread vs growth
119.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.4%
Start / end P/E
19.1x → 5.2x
EPS bridge
18.12 → 39.65
Residual
-86.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.